TrialPharmacoEconomics2013

Real-world cost-effectiveness of oxaliplatin in stage III colon cancer: a synthesis of clinical trial and daily practice evidence.

Chantal W M van Gils et al.PubMed ↗Publisher ↗

No numbers read from the abstract.